Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...
The Scientist6mon
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
This single test interrogates over 500 genes to profile a patient ... Early-Phase Drug Development at Sarah Cannon Research Institute. “Illumina’s newest distributable IVD kit for comprehensive ...
What Makes Illumina (ILMN) an Attractive Opportunity?
Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the letter ...
technologynetworks2y
Invitrogen™ Collibri™ DNA Library Prep Kits for Illumina™ Systems
The Invitrogen Collibri DNA Library Prep Kits prepare libraries for whole-genome sequencing (WGS) on Illumina NGS systems and contain tracking dyes to quickly and easily visualize library prep ...